PapersFlow Research Brief
Antibiotics Pharmacokinetics and Efficacy
Research Guide
What is Antibiotics Pharmacokinetics and Efficacy?
Antibiotics Pharmacokinetics and Efficacy is the study of how antibiotics are absorbed, distributed, metabolized, and excreted in the body, particularly in critically ill patients, and how these processes influence their ability to inhibit or kill bacteria.
This field examines drug dosing, therapeutic drug monitoring, and factors like augmented renal clearance that affect antibiotic levels in critically ill patients. It addresses antimicrobial resistance through pharmacokinetic and pharmacodynamic principles for beta-lactam antibiotics, aminoglycosides, and continuous infusion strategies. The cluster includes 93,513 papers with growth data unavailable over the past 5 years.
Topic Hierarchy
Research Sub-Topics
Beta-lactam Antibiotics Pharmacokinetics
This sub-topic examines the absorption, distribution, metabolism, and excretion of beta-lactam antibiotics like piperacillin and meropenem in various patient populations. Researchers optimize dosing regimens using population pharmacokinetic models to achieve therapeutic targets.
Therapeutic Drug Monitoring of Antibiotics
Therapeutic drug monitoring (TDM) for antibiotics involves measuring plasma concentrations to individualize dosing, particularly for vancomycin and aminoglycosides. Studies validate TDM protocols in ICU settings and assess clinical outcomes like efficacy and toxicity.
Augmented Renal Clearance in Critically Ill
Augmented renal clearance (ARC) describes hyperfiltration in critically ill patients leading to subtherapeutic antibiotic levels. Research identifies ARC predictors, prevalence, and impact on beta-lactam efficacy using creatinine clearance measurements.
Continuous Infusion Antibiotic Administration
Continuous infusion of time-dependent antibiotics like beta-lactams maintains concentrations above MIC for optimal pharmacodynamics. Clinical trials compare continuous vs. intermittent dosing in terms of PK profiles and patient outcomes.
Pharmacodynamics of Antibiotics Against Resistance
Antibiotic pharmacodynamics studies exposure-response relationships against resistant pathogens, including MIC distributions and PK/PD indices. Researchers model mutant prevention concentrations to suppress resistance emergence.
Why It Matters
Pharmacokinetic optimization ensures adequate antibiotic exposure in critically ill patients to combat infections and mitigate resistance. "Performance standards for antimicrobial susceptibility testing" by Mary Jane Ferraro (2001) established benchmarks cited 9765 times for testing efficacy against resistant strains. "Determination of minimum inhibitory concentrations" by Jennifer M. Andrews (2001) defined MICs as the lowest concentration inhibiting visible bacterial growth after overnight incubation, guiding dosing with 3979 citations. These standards support therapeutic drug monitoring to achieve target concentrations, reducing treatment failures in settings like severe COVID-19 where lopinavir-ritonavir showed no benefit beyond standard care per Bin Cao et al. (2020).
Reading Guide
Where to Start
"Performance standards for antimicrobial susceptibility testing" by Mary Jane Ferraro (2001) is the starting point as the most-cited paper (9765 citations) providing foundational testing benchmarks essential for understanding efficacy assessment.
Key Papers Explained
"Performance standards for antimicrobial susceptibility testing" by Mary Jane Ferraro (2001) establishes susceptibility benchmarks, complemented by "Determination of minimum inhibitory concentrations" by Jennifer M. Andrews (2001) defining MICs and MBCs. "Pharmacokinetics" by Milo Gibaldi and Donald Perrier (1982) provides the core principles of drug behavior in the body. These connect through shared focus on measurement standards and kinetics underpinning dosing.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Research emphasizes pharmacokinetic variability in critically ill patients, with ongoing needs for dosing in augmented renal clearance. Preprints and news are unavailable, so frontiers remain in applying standards from Ferraro (2001) and Weinstein (2019) to resistance challenges noted by Ventola (2015).
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Performance standards for antimicrobial susceptibility testing | 2001 | — | 9.8K | ✕ |
| 2 | A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Sev... | 2020 | New England Journal of... | 5.5K | ✓ |
| 3 | Emergence of plasmid-mediated colistin resistance mechanism MC... | 2015 | The Lancet Infectious ... | 5.2K | ✕ |
| 4 | The antibiotic resistance crisis: part 1: causes and threats. | 2015 | PubMed | 4.7K | ✓ |
| 5 | Performance standards for antimicrobial susceptibility testing | 2019 | Clinical and Laborator... | 4.4K | ✕ |
| 6 | Antibiotics in the aquatic environment – A review – Part I | 2009 | Chemosphere | 4.3K | ✕ |
| 7 | Antibiotic resistance—the need for global solutions | 2013 | The Lancet Infectious ... | 4.2K | ✓ |
| 8 | Pharmacokinetics | 1982 | — | 4.1K | ✕ |
| 9 | Determination of minimum inhibitory concentrations | 2001 | Journal of Antimicrobi... | 4.0K | ✓ |
| 10 | Occurrence of drugs in German sewage treatment plants and rivers | 1998 | Water Research | 3.4K | ✕ |
Frequently Asked Questions
What are minimum inhibitory concentrations (MICs)?
MICs are the lowest concentration of an antimicrobial that inhibits visible growth of a microorganism after overnight incubation. Minimum bactericidal concentrations (MBCs) are the lowest concentration preventing growth on subculture. "Determination of minimum inhibitory concentrations" by Jennifer M. Andrews (2001) provides this definition.
How does augmented renal clearance impact antibiotic pharmacokinetics?
Augmented renal clearance in critically ill patients lowers antibiotic levels, requiring adjusted dosing. This affects beta-lactam antibiotics and aminoglycosides. Therapeutic drug monitoring addresses these variations.
What role do performance standards play in antimicrobial susceptibility testing?
"Performance standards for antimicrobial susceptibility testing" by Mary Jane Ferraro (2001) sets criteria for evaluating antibiotic efficacy, cited 9765 times. Melvin P. Weinstein (2019) updated these standards for clinical use. They guide susceptibility reporting.
Why is therapeutic drug monitoring used for antibiotics?
Therapeutic drug monitoring ensures antibiotic concentrations reach pharmacodynamic targets in critically ill patients. It accounts for factors like continuous infusion and resistance. This optimizes efficacy and minimizes toxicity.
What causes the antibiotic resistance crisis?
The crisis stems from antibiotic abuse and insufficient new drug development, making infections threatening again. "The antibiotic resistance crisis: part 1: causes and threats" by C Lee Ventola (2015) attributes it to decades of overuse, with 4662 citations. Global solutions are needed per Ramanan Laxminarayan et al. (2013).
How do pharmacokinetics influence antibiotic dosing?
Pharmacokinetics describes absorption, distribution, metabolism, and excretion of antibiotics. "Pharmacokinetics" by Milo Gibaldi and Donald Perrier (1982) covers these processes, cited 4074 times. Dosing adjustments are critical in critically ill patients.
Open Research Questions
- ? How can dosing regimens be optimized for beta-lactam antibiotics in patients with augmented renal clearance?
- ? What pharmacodynamic targets best predict efficacy for aminoglycosides under continuous infusion?
- ? How do plasmid-mediated resistance mechanisms like MCR-1 alter pharmacokinetic requirements?
- ? Which therapeutic drug monitoring strategies most effectively overcome variability in critically ill patients?
- ? How can susceptibility testing standards be refined to better predict clinical outcomes?
Recent Trends
The field spans 93,513 papers, but 5-year growth data is unavailable.
Highly cited works like "Performance standards for antimicrobial susceptibility testing" by Melvin P. Weinstein with 4380 citations reflect sustained focus on updated testing amid resistance, as in "The antibiotic resistance crisis: part 1: causes and threats" by C Lee Ventola (2015).
2019No recent preprints or news available indicate steady reliance on established standards.
Research Antibiotics Pharmacokinetics and Efficacy with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Antibiotics Pharmacokinetics and Efficacy with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers